NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RACA | Therapeutics Acquisition Corp | Financial Services | Shell Companies | 2.39% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 2.3% |
| RAIN | Rain Therapeutics Inc | Healthcare | Biotechnology | 1.7% |
| HCM | HUTCHMED DRC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.57% |
| NUVL | Nuvalent Inc | Healthcare | Biotechnology | 1.47% |
| MRSN | Mersana Therapeutics Inc | Healthcare | Biotechnology | 1.46% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.44% |
| YMAB | Y mAbs Therapeutics | Healthcare | Biotechnology | 1.44% |
| MGNX | MacroGenics Inc | Healthcare | Biotechnology | 1.42% |
| SGEN | Seagen Inc | Healthcare | Biotechnology | 1.41% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.38% |
| EQRX | EQRx Inc | Healthcare | Biotechnology | 1.37% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 1.37% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.35% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.35% |
| EXAI_old | EXAI | Healthcare | Biotechnology | 1.34% |
| VOR | Vor Biopharma Inc | Healthcare | Biotechnology | 1.33% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.32% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.31% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.31% |
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.